The subject of the contract is the delivery, as part of separate tasks (packages) of cytostatic drugs that meet the requirements specified in the catalogs of reimbursed drugs used in drug programs specified in the Regulation No. 75/2018 / DGL of the President of the National Health Fund of 31.7.2018 on determining the conditions for concluding and implementation of contracts such as hospital treatment in the field of drug programs (as amended), in the range and amounts specified in detail in Annex 4 to the ToR.

The scope of the contract includes the cytostatic drug Palbociclib, which is described in detail in Annex 4 to the ToR - an assortment and price form.

The scope of the contract includes the cytostatic drug Rybociclib, which is described in detail in Annex 4 to the ToR - the assortment and price form.

The scope of the order includes the Pomalidomide cytostatic drug which is described in detail in Annex 4 to the ToR - an assortment and price form.

The scope of the contract includes the cytostatic drug Daratumumab which is described in detail in Annex 4 to the ToR - an assortment and price form.